Phase 4 N=117 The Impact of Omega Three Fatty Acids on Vascular Function in HIV
High Triglyceride Level · HIV Infection
Primary: Triglyceride Level — 130; 159 mg/dL
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=14 Critical Time Intervention for Individuals With Hoarding Disorder
Hoarding Disorder
Primary: Savings Inventory-Revised — 67.5; 57.2; 54.8; 51.3 units on a scale
Phase 2 N=228 LACTIN-V Study for Recurrent Bacterial Vaginosis
Bacterial Vaginosis
Primary: The Proportion of Participants Reporting Product-related Adverse Events (AEs) and Serious Adverse Events (SAEs) in Each Study Arm. — 0.11; 0.07 proportion of…
N/A N=100 Treatment of Depression in Acute Coronary Syndrome (ACS) Patients
Depression
Primary: Depression and Well-being Improvements After Cognitive-Behavioral Therapy and Well-Being Therapy as Assessed by Changes in Clinical Interview for Depression, Compared to…
Phase 1 N=8 Facilitating the Behavioral Treatment of Cannabis Use Disorder
Cannabis Dependence
Primary: Percentage of Participants With Cannabis Abstinence or Significant Reduction in Cannabis Use — 7 Participants
Phase 3 N=67 A Study to Evaluate Efficacy and Safety of TEZ/IVA in Subjects Aged 6 Through 11 Years With Cystic Fibrosis
Cystic Fibrosis
Primary: Absolute Change in Lung Clearance Index 2.5 (LCI2.5) Through Week 8 — -0.51 lung clearance index — p=<0.0001
N/A N=5 Augmenting Buried in Treasures Workshop (BIT) With In-home Decluttering Practice for Individuals With Hoarding Disorder
Hoarding Disorder
Primary: Savings Inventory Revised — 71; 55; 53 units on a scale
Phase 3 N=94 ENVISION: A Study to Evaluate the Efficacy and Safety of Givosiran (ALN-AS1) in Patients With Acute Hepatic Porphyrias (AHP)
Acute Hepatic Porphyria · Acute Intermittent Porphyria · Porphyria, Acute Intermittent
Primary: Annualized Rate of Porphyria Attacks in Participants With Acute Intermittent Porphyria (AIP) — 12.52; 3.22 annualized attack rate — p=<0.0001
N/A N=482 Special Investigation Of Genotropin Long Follow-Up For Patients With A Small For Gestational Age "Scoped for Japanese"
Small for Gestational Age (SGA)
Primary: Number of Participants With Adverse Drug Reaction (ADR) — 24; 4 Participants
Phase 3 N=162 Safety and Effectiveness of BPL HRIG With Active Rabies Vaccine in Healthy Subjects
Healthy
Primary: Proportion of Subjects With Anti-rabies Antibody Titer of ≥0.5 IU/mL — 73; 72 Participants — p=0.0006
N/A N=60 Prevalence of Second Mesiobuccal Canal of Maxillary First and Second Molars Among Egyptian Population
Second Mesiobuccal Canal · Maxillary First and Second Molars
Primary: Number of Maxillary Molars With a Second Mesiobuccal Canal — 86 molar teeth
N/A N=81 Integrated Treatment of OEF/OIF Veterans With PTSD & Substance Use Disorders
Posttraumatic Stress Disorders · Combat Disorders · Alcohol Dependence
Primary: Change in Post-traumatic Stress Disorder Symptomatology — -51.2; -35.9; -22.3; -10.9 score on a scale
N/A N=66 "Liposomal Encapsulated Vitamin C in Complex Regional Pain Syndrome"
Complex Regional Pain Syndrome I of Lower Limb
Primary: Number of Participants Operated for Complex Regional Pain Syndrome Who Had Transposition of Anterior Tibial Tuberosity — 1; 0; 2 participants
N/A N=10 Evaluation of Coronary Artery Calcification Using Gated Stationary Chest Tomosynthesis
Coronary Artery Disease
Primary: Comparison of CT Derived CACS and Tomosynthesis Scores Correlation
Phase 3 N=1,006 Study of the Efficacy and Safety of Lemborexant in Subjects 55 Years and Older With Insomnia Disorder (SUNRISE 1)
Insomnia
Primary: Change From Baseline in Mean Latency to Persistent Sleep (LPS) of Lemborexant 10 mg and Lemborexant 5 mg Compared to Placebo on Days 29/30 — 43.89; 44.86; 44.61; -7.93…